AAAAAA
Results:
1-10
|
Results: 10
Authors:
JOYCE R
FENTON MA
RODE P
CONSTANTINE M
GAYNES L
KOLVENBAG G
DEWOLF W
BALK S
TAPLIN ME
BUBLEY GJ
Citation: R. Joyce et al., HIGH-DOSE BICALUTAMIDE FOR ANDROGEN-INDEPENDENT PROSTATE-CANCER - EFFECT OF PRIOR HORMONAL-THERAPY, The Journal of urology, 159(1), 1998, pp. 149-153
Authors:
FENTON MA
SHUSTER TD
FERTIG AM
TAPLIN ME
KOLVENBAG G
BUBLEY GJ
BALK SP
Citation: Ma. Fenton et al., FUNCTIONAL-CHARACTERIZATION OF MUTANT ANDROGEN RECEPTORS FROM ANDROGEN-INDEPENDENT PROSTATE-CANCER, Clinical cancer research, 3(8), 1997, pp. 1383-1388
Authors:
SCHER HI
LIEBERTZ C
KELLY WK
MAZUMDAR M
BRETT C
SCHWARTZ L
KOLVENBAG G
SHAPIRO L
SCHWARTZ M
Citation: Hi. Scher et al., BICALUTAMIDE FOR ADVANCED PROSTATE-CANCER - THE NATURAL VERSUS TREATED HISTORY OF DISEASE, Journal of clinical oncology, 15(8), 1997, pp. 2928-2938
Authors:
BLACKLEDGE G
KOLVENBAG G
NASH A
Citation: G. Blackledge et al., BICALUTAMIDE - A NEW ANTIANDROGEN FOR USE IN COMBINATION WITH CASTRATION FOR PATIENTS WITH ADVANCED PROSTATE-CANCER, Anti-cancer drugs, 7(1), 1996, pp. 27-34
Authors:
SOLOWAY MS
SCHELLHAMMER P
SHARIFI R
VENNER P
PATTERSON AL
SAROSDY M
VOGELZANG N
JONES J
KOLVENBAG G
Citation: Ms. Soloway et al., A CONTROLLED TRIAL OF CASODEX(TM) (BICALUTAMIDE) VS FLUTAMIDE, EACH IN COMBINATION WITH LUTEINIZING-HORMONE-RELEASING HORMONE ANALOG THERAPY IN PATIENTS WITH ADVANCED PROSTATE-CANCER, European urology, 29, 1996, pp. 105-109
Authors:
SCHELLHAMMER P
SHARIFI R
BLOCK N
SOLOWAY M
VENNER P
PATTERSON AL
SAROSDY M
VOGELZANG N
JONES J
KOLVENBAG G
Citation: P. Schellhammer et al., MAXIMAL ANDROGEN BLOCKADE FOR PATIENTS WITH METASTATIC PROSTATE-CANCER - OUTCOME OF A CONTROLLED TRIAL OF BICALUTAMIDE VERSUS FLUTAMIDE, EACH IN COMBINATION WITH LUTEINIZING-HORMONE-RELEASING HORMONEANALOGUE THERAPY, Urology, 47(1A), 1996, pp. 54-60
Authors:
VOGELZANG NJ
SCHELLHAMMER PF
SHARIFI R
BLOCK NL
SOLOWAY MS
VENNER PM
PATTERSON AL
SAROSDY MF
JONES JA
KOLVENBAG G
Citation: Nj. Vogelzang et al., A RANDOMIZED DOUBLE-BLIND TRIAL IN 813 PREVIOUSLY UNTREATED METASTATIC PROSTATE-CANCER (CAP) PATIENTS (PTS) COMPARING A NEW ANTIANDROGEN CASODEX(R) (BICALUTAMIDE) WITH EULEXIN (FLUTAMIDE) IN COMBINATION WITH LUTEINIZING-HORMONE-RELEASING HORMONE ANALOG (LHRH-A) THERAPY, European journal of cancer, 31A, 1995, pp. 456-456
Authors:
SCHELLHAMMER P
VOGELZANG N
JONES J
KOLVENBAG G
Citation: P. Schellhammer et al., A CONTROLLED TRIAL OF BICALUTAMIDE VERSUS FLUTAMIDE, EACH IN COMBINATION WITH LUTEINIZING-HORMONE-RELEASING HORMONE ANALOG THERAPY, IN PATIENTS WITH ADVANCED PROSTATE-CANCER - REPLY, Urology, 46(6), 1995, pp. 899-901
Authors:
SCHELLHAMMER P
SHARIFI R
BLOCK N
SOLOWAY M
VENNER P
PATTERSON AL
SAROSDY M
VOGELZANG N
JONES J
KOLVENBAG G
Citation: P. Schellhammer et al., A CONTROLLED TRIAL OF BICALUTAMIDE VERSUS FLUTAMIDE, EACH IN COMBINATION WITH LUTEINIZING-HORMONE-RELEASING HORMONE ANALOG THERAPY, IN PATIENTS WITH ADVANCED PROSTATE-CANCER, Urology, 45(5), 1995, pp. 745-752
Authors:
DEHAES JCJM
OLSCHEWSK M
JONAT W
KAUFMANN M
SCHUMACHER M
KOLVENBAG G
Citation: Jcjm. Dehaes et al., QUALITY-OF-LIFE ASSESSMENT IN AN INTERNATIONAL, RANDOMIZED TRIAL COMPARING ZOLADEX WITH CMF IN PREMENOPAUSAL, NODE-POSITIVE BREAST-CANCER PATIENTS, Quality of life research, 3(1), 1994, pp. 73-74
Risultati:
1-10
|